CN Patent

CN107260692A — 药物组合物和其给药方法

Assigned to Vertex Pharmaceuticals Inc · Expires 2017-10-20 · 9y expired

What this patent protects

药物组合物，其包含化合物1，(3‑(6‑(1‑(2,2‑二氟苯并[d][1,3]二氧杂环戊烯‑5‑基)环丙甲酰胺基)‑3‑甲基吡啶‑2‑基)苯甲酸)和至少一种选自下列的赋形剂：填料，稀释剂，崩解剂，表面活性剂，粘合剂，助流剂和润滑剂，该组合物适合于口服给予需要其的患者，用于治疗CFTR介导的疾病，例如囊性纤维化。治疗需要其的患者的方法，包括口服给予患者化合物1的药物制剂。

USPTO Abstract

药物组合物，其包含化合物1，(3‑(6‑(1‑(2,2‑二氟苯并[d][1,3]二氧杂环戊烯‑5‑基)环丙甲酰胺基)‑3‑甲基吡啶‑2‑基)苯甲酸)和至少一种选自下列的赋形剂：填料，稀释剂，崩解剂，表面活性剂，粘合剂，助流剂和润滑剂，该组合物适合于口服给予需要其的患者，用于治疗CFTR介导的疾病，例如囊性纤维化。治疗需要其的患者的方法，包括口服给予患者化合物1的药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN107260692A
Jurisdiction
CN
Classification
—
Expires
2017-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.